Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

被引：0
|
作者：
Carlo Mümmler
Bernd Kemmerich
Jürgen Behr
Nikolaus Kneidinger
Katrin Milger
机构：
[1] Ludwig-Maximilians-University of Munich (LMU),Department of Internal Medicine V
[2] Comprehensive Pneumology Center (CPC-M),undefined
[3] Member of the German Center for Lung Research (DZL),undefined
[4] Pneumologie an der Münchner Freiheit,undefined
来源：
Allergy, Asthma & Clinical Immunology | / 16卷
关键词：
ABPA; Aspergillosis; Asthma; Dupilumab; IL13; IL4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
    Muemmler, Carlo
    Kemmerich, Bernd
    Behr, Juergen
    Kneidinger, Nikolaus
    Milger, Katrin
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [2] Super-response to dupilumab therapy in a patient with severe asthma and ABPA - a case report
    Muemmler, Carlo
    Kemmerich, Bernd
    Milger-Kneidinger, Katrin
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [3] The Role of Dupilumab in Severe Asthma
    Ricciardolo, Fabio Luigi Massimo
    Bertolini, Francesca
    Carriero, Vitina
    BIOMEDICINES, 2021, 9 (09)
  • [4] Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)
    Milger, Katrin
    Korn, Stephanie
    Feder, Claudia
    Fuge, Jan
    Muehle, Andreas
    Schuette, Wolfgang
    Skowasch, Dirk
    Timmermann, Hartmut
    Suhling, Hendrik
    PNEUMOLOGIE, 2023, 77 (04): : 220 - 232
  • [5] Criteria for evaluation of response to biologics in severe asthma - the Biologics Asthma Response Score (BARS)
    Milger, Katrin
    Korn, Stephanie
    Feder, Claudia
    Fuge, Jan
    Muehle, Andreas
    Schuette, Wolfgang
    Skowasch, Dirk
    Timmermann, Hartmut
    Suhling, Hendrik
    PNEUMOLOGIE, 2023,
  • [6] Criteria for Evaluating Response to Biologics in severe Asthma- the Biologics Asthma Response Score (BARS)
    Milger-Kneidinger, K.
    Korn, S.
    Feder, C.
    Fuge, J.
    Muhle, A.
    Schutte, W.
    Skowasch, D.
    Timmermann, H.
    Suhling, H.
    PNEUMOLOGIE, 2023, 77 : S108 - S108
  • [7] Adverse Effects Under Th2 Biologics (Dupilumab and Tezepelumab) in a Patient with Severe Asthma and Atopic Dermatitis
    Suhling, Hendrik
    Hinze, Christopher Alexander
    Welte, Tobias
    Werfel, Thomas
    Traidl, Stephan
    RESPIRATION, 2023, 102 (12) : 1016 - 1019
  • [8] Things to keep in mind in the differential diagnosis of severe asthma: ABPA and EGPA
    Ozden, S.
    Merve, T. Fatma
    ALLERGY, 2023, 78
  • [9] Graves disease in a patient treated with dupilumab for severe asthma
    Tang, Haoming
    Ho, Wen
    Wang, Samuel
    Lau, Siaw
    Seah, Charlotte
    Loo, Wesley
    INTERNAL MEDICINE JOURNAL, 2024, 54 (04) : 689 - 690
  • [10] Effect of dupilumab treatment in a severe asthma patient with EGPA
    Matucci, Andrea
    Bormioli, Susanna
    Bercich, Luisa
    Comin, Camilla E.
    Bezzi, Michela
    Vivarelli, Emanuele
    Vultaggio, Alessandra
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10): : 3824 - 3825
12345